Nuvo Research® is a specialty pharmaceutical company with a diverse portfolio of products and technologies.

WF10™ is a solution containing stabilized chlorite ions that focuses on supporting the immune system by targeting the macrophage, a type of white blood cell that coordinates much of the immune system to regulate normal immune function.

The Company is developing WF10 for the treatment of allergic rhinitis. The Company is executing a Phase 2 study with top-line results expected in mid-February 2015.